Stagnant performance at new pharmacies due to delays in patient intake at newly opened hospitals

Risk that delays in patient intake and operational readiness at newly opened large hospitals will delay the ramp-up in patient numbers and sales at new pharmacies adjacent to or affiliated with the hospitals, resulting in stagnant performance, including pre-opening costs.